LIPID MODIFYING AGENTS: MECHANISMS OF ACTION AND REDUCTION OF CARDIOVASCULAR DISEASE
Author:
Publisher
Wiley
Subject
Physiology (medical),Pharmacology,Physiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1681.1997.tb03050.x/fullpdf
Reference27 articles.
1. Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
3. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
4. The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Low density lipoprotein receptor endocytosis in cardiovascular disease and the factors affecting LDL levels;Progress in Molecular Biology and Translational Science;2023
2. Changes in plasma lipids predict pravastatin efficacy in secondary prevention;JCI Insight;2019-07-11
3. Hibiscus sabdariffa extract reduces serum cholesterol in men and women;Nutrition Research;2007-03
4. Alcohol Use, Vascular Disease, and Lipid-Lowering Drugs;Journal of Pharmacology and Experimental Therapeutics;2006-04-20
5. Lipid-lowering properties of 6-benzoyl-2(3H)-benzothiazolone and structurally related compounds;Journal of Enzyme Inhibition and Medicinal Chemistry;2005-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3